JP2010207229A5 - - Google Patents

Download PDF

Info

Publication number
JP2010207229A5
JP2010207229A5 JP2010089887A JP2010089887A JP2010207229A5 JP 2010207229 A5 JP2010207229 A5 JP 2010207229A5 JP 2010089887 A JP2010089887 A JP 2010089887A JP 2010089887 A JP2010089887 A JP 2010089887A JP 2010207229 A5 JP2010207229 A5 JP 2010207229A5
Authority
JP
Japan
Prior art keywords
seq
sequence number
sle
gene
test sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010089887A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010207229A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2010207229A publication Critical patent/JP2010207229A/ja
Publication of JP2010207229A5 publication Critical patent/JP2010207229A5/ja
Pending legal-status Critical Current

Links

JP2010089887A 2003-03-03 2010-04-08 全身性エリテマトーデスの治療のための組成物と方法 Pending JP2010207229A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US45188403P 2003-03-03 2003-03-03

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2006532309A Division JP2008500009A (ja) 2003-03-03 2004-03-02 全身性エリテマトーデスの治療のための組成物と方法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013121971A Division JP2013240329A (ja) 2003-03-03 2013-06-10 全身性エリテマトーデスの治療のための組成物と方法

Publications (2)

Publication Number Publication Date
JP2010207229A JP2010207229A (ja) 2010-09-24
JP2010207229A5 true JP2010207229A5 (enExample) 2011-07-14

Family

ID=34632721

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2006532309A Pending JP2008500009A (ja) 2003-03-03 2004-03-02 全身性エリテマトーデスの治療のための組成物と方法
JP2010089887A Pending JP2010207229A (ja) 2003-03-03 2010-04-08 全身性エリテマトーデスの治療のための組成物と方法
JP2013121971A Pending JP2013240329A (ja) 2003-03-03 2013-06-10 全身性エリテマトーデスの治療のための組成物と方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2006532309A Pending JP2008500009A (ja) 2003-03-03 2004-03-02 全身性エリテマトーデスの治療のための組成物と方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013121971A Pending JP2013240329A (ja) 2003-03-03 2013-06-10 全身性エリテマトーデスの治療のための組成物と方法

Country Status (6)

Country Link
US (2) US7749695B2 (enExample)
EP (1) EP1599498A2 (enExample)
JP (3) JP2008500009A (enExample)
AU (2) AU2004293369A1 (enExample)
CA (1) CA2518101A1 (enExample)
WO (1) WO2005051988A2 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7790861B2 (en) * 1999-09-24 2010-09-07 Philadelphia Health And Education Corporation Prostate cancer-related compositions, methods, and kits based on DNA macroarray proteomics platforms
US20020042062A1 (en) * 1999-09-24 2002-04-11 Mark Stearns Prostate cancer-related compositions, methods, and kits based on DNA macroarray proteomics platforms
US7754435B2 (en) * 2000-09-21 2010-07-13 Philadelphia Health And Education Corporation Prostate cancer-related compositions, methods, and kits based on DNA macroarray proteomics platforms
WO2007043103A1 (ja) * 2005-09-30 2007-04-19 Kansai Technology Licensing Organization Co., Ltd. シェーグレン症候群診断法及び診断キット
EP2044213A2 (en) * 2006-04-24 2009-04-08 Genentech, Inc. Methods and compositions for detecting autoimmune disorders
WO2007138011A1 (en) * 2006-05-25 2007-12-06 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for diagnosing and treating graft rejection and inflammatory conditiions
EP1905841A1 (en) * 2006-09-25 2008-04-02 Max Delbrück Centrum für Molekulare Medizin (MDC) Berlin-Buch; Trex1 as a marker for lupus erythematosus
US20110281750A1 (en) * 2008-07-24 2011-11-17 The Regents Of The University Of California, A California Corporation Identifying High Risk Clinically Isolated Syndrome Patients
CA2772921A1 (en) * 2009-09-03 2011-03-10 Medimmune, Llc Type 1 interferon diagnostic
WO2012042480A1 (en) 2010-09-28 2012-04-05 Kahr Medical Ltd. Compositions and methods for treatment of hematological malignancies
ES2949865T3 (es) 2012-03-28 2023-10-03 Gadeta B V Intercambio combinatorio de cadena de receptores de células T gamma 9 delta 2
ES2987986T3 (es) 2016-06-10 2024-11-18 Gadeta B V Nuevo método para identificar cadenas de receptores de células T delta (o células T gamma) o partes de estas que intervienen en una respuesta antitumoral o antiinfecciosa
JP2019535834A (ja) * 2016-11-18 2019-12-12 ユニベルシタ デ バルセロナ 感染症及び関連炎症プロセスの処置のためのｃｄ６及びイミペネムの併用療法
KR102573778B1 (ko) 2017-02-17 2023-08-31 브리스톨-마이어스 스큅 컴퍼니 알파-시뉴클레인에 대한 항체 및 그의 용도
AU2019207951A1 (en) * 2018-01-09 2020-07-02 Imagine Pharma, Llc Use of RPS2 peptides for modulating endothelial cell dysfunction
GB202012804D0 (en) * 2020-08-17 2020-09-30 Univ London Queen Mary Agrin polypeptide and uses thereof

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992016660A1 (en) * 1991-03-22 1992-10-01 Sloan-Kettering Institute For Cancer Research Methods for detection and treatment of cancer
AU6498499A (en) * 1998-09-17 2000-04-03 Genentech Inc. Compositions and methods for the treatment of immune related diseases
AU3514400A (en) * 1999-03-08 2000-09-28 Genentech Inc. Compositions and methods for the treatment of immune related diseases
AU3628600A (en) * 1999-03-19 2000-10-09 Human Genome Sciences, Inc. 46 human secreted proteins
CA2390786A1 (en) * 1999-11-30 2001-06-07 Genentech, Inc. Compositions and methods for the treatment of immune related diseases
ATE541930T1 (de) * 1999-12-23 2012-02-15 Genentech Inc Il-17-homologe polypeptide und ihre therapeutische verwendung
WO2001057190A2 (en) * 2000-02-03 2001-08-09 Hyseq, Inc. Novel nucleic acids and polypeptides
EP1276702A2 (en) 2000-03-31 2003-01-22 Genentech, Inc. Compositions and methods for detecting and quantifying gene expression
US6436703B1 (en) 2000-03-31 2002-08-20 Hyseq, Inc. Nucleic acids and polypeptides
AU2001274888A1 (en) * 2000-05-19 2001-12-03 Human Genome Sciences, Inc. Nucleic acids, proteins, and antibodies
EP1330543A4 (en) * 2000-10-02 2006-03-29 Bayer Ag IN CANCER TISSUE, EXPRESSED NUCLEIC ACID SEQUENCES DIFFERENTIATE
US20020137081A1 (en) * 2001-01-08 2002-09-26 Olga Bandman Genes differentially expressed in vascular tissue activation
CA2435260A1 (en) 2001-01-19 2002-07-25 Incyte Genomics, Inc. Receptors and membrane-associated proteins
WO2003010327A2 (en) * 2001-02-21 2003-02-06 Curagen Corporation Novel proteins and nucleic acids encoding same
US20070015145A1 (en) * 2001-08-14 2007-01-18 Clifford Woolf Nucleic acid and amino acid sequences involved in pain
US6489153B1 (en) * 2001-10-31 2002-12-03 Pe Corporation (Ny) Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
WO2003072035A2 (en) * 2002-02-22 2003-09-04 Genentech, Inc. Compositions and methods for the treatment of immune related diseases
JP2004121218A (ja) * 2002-08-06 2004-04-22 Jenokkusu Soyaku Kenkyusho:Kk 気管支喘息または慢性閉塞性肺疾患の検査方法
US7118865B2 (en) * 2002-08-16 2006-10-10 Regents Of The University Of Minnesota Methods for diagnosing severe systemic lupus erythematosus
EP1578373A4 (en) 2002-09-11 2007-10-24 Genentech Inc NEW COMPOSITIONS AND METHOD FOR THE TREATMENT OF ILLNESSES OF THE IMMUNE SYSTEM
CA2499843A1 (en) * 2002-09-25 2004-04-08 Genentech, Inc. Novel compositions and methods for the treatment of psoriasis
US20070224201A1 (en) * 2002-10-02 2007-09-27 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
EP1578368A4 (en) * 2002-11-12 2008-01-23 Genentech Inc COMPOSITIONS AND METHOD FOR THE TREATMENT OF RHEUMATOID ARTHRITIS
US20070048301A1 (en) * 2002-11-26 2007-03-01 Bodary-Winter Sarah C Compositions and methods for the treatment of immune related diseases
WO2004076639A2 (en) * 2003-02-26 2004-09-10 Wyeth Use of gene expression profiling in the diagnosis and treatment of lupus nephritis and systemic lupus erythematosus

Similar Documents

Publication Publication Date Title
JP2010207229A5 (enExample)
JP2010115195A5 (enExample)
Su et al. Determination of endotoxin through an aptamer-based impedance biosensor
WO2012075506A3 (en) Methods for predicting and treating infection-induced illnesses and predicting the severity of infection-induced illnesses
JP2013521763A5 (enExample)
CN101846648A (zh) 石墨烯量子点修饰的电化学生物传感器及其制备方法
WO2012080754A3 (en) Oligonucleotide probe set and methods of microbiota profiling
JP2014525584A5 (enExample)
JP2010532986A5 (enExample)
AR085282A1 (es) Antigeno de maduracion de celulas b que se utiliza para fines diagnosticos y terapeuticos
JP2013511735A5 (enExample)
RU2016106583A (ru) Пептиды, способные реактивировать мутанты р53
JP2011516038A5 (enExample)
JP2012501318A5 (enExample)
WO2009047283A3 (en) Means and methods for monitoring myocardial infarction and its treatment
Chen et al. A one-step electrochemical sensor for rapid detection of potassium ion based on structure-switching aptamer
WO2013010181A3 (en) Methods of diagnosing cancer using epigenetic biomarkers
CN104931570A (zh) 一种基于核酸适配体的重金属离子电化学传感器的制备方法及应用
JP2014501929A5 (enExample)
JP2011515672A5 (enExample)
WO2014177867A3 (en) Differentially expressed biomarkers for alzheimer's disease
WO2011112749A3 (en) Semi-invasive method for characterizing lung injury
JP2006503575A5 (enExample)
WO2009031818A3 (en) Biomarker for purification or identification of mesenchymal stem cells and methods of purification of mesenchymal stem cells by using it
RU2014115533A (ru) Диагностика туберкулеза